# NIMH SBIR PHASE 1 TOPIC 001- POINT-OF-CARE HIV VIRAL LOAD AND DRUG ADHERENCE ASSAYS

> **NIH NIH N43** · VITRUVIAN BIO, LLC · 2024 · $299,999

## Abstract

This Phase I SBIR contract is in support of Development of an Integrated Viral Load and Pharmacological Adherence Monitoring Device for point-of-care or self-monitoring of HIV infection upon the completion of phase I, a prototype sensor device that can provide a qualitative result to a user regarding their HIV viral load and therapeutic drug concentration will be developed. these results can then be passed on to a physician if needed.

## Key facts

- **NIH application ID:** 11222472
- **Project number:** 75N95024C00040-0-9999-1
- **Recipient organization:** VITRUVIAN BIO, LLC
- **Principal Investigator:** ANGANA SENPEN
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $299,999
- **Award type:** —
- **Project period:** 2024-09-23 → 2025-09-22

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11222472

## Citation

> US National Institutes of Health, RePORTER application 11222472, NIMH SBIR PHASE 1 TOPIC 001- POINT-OF-CARE HIV VIRAL LOAD AND DRUG ADHERENCE ASSAYS (75N95024C00040-0-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11222472. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*